The joint announcement made by BASF, MedAccess and the Bill & Melinda Gates Foundation last month is a key achievement for public private partnership and reflects the commitment of organizations such as IVCC who partnered with BASF to support the development of the Interceptor® G2 nets. It also supports the objectives of the New Nets Project, co-financed by the Global Fund to Fight AIDS, Tuberculosis and Malaria and Unitaid, and led by IVCC.
IVCC worked with BASF to support the development and registration of Interceptor® G2 and this ground-breaking product represents a key achievement for the PDP model of product development and collaboration with industry.
IVCC has developed and led the NNP project to bring together the partnerships required to deliver the multiple interventions required to optimise effective scale up of this and other exciting new products.
See full announcement on the right.IVCC supporting PAMCA 7th October 2019
IVCC had a strong presence at this years’ Pan African Mosquito Control Association (PAMCA) conference held in Yaoundé, Cameroon in September. Derric Nimmo, Technical Manager IVCC, Allison Tatarsky, University of California, San Francisco, Malaria Elimination Initiative and RBM VCWG New Tools, New Challenges and Fredros Okumu from the Ifakara Health Institute, Tanzania, co-organised a symposium entitled ‘Vector Control Innovations to drive progress in malaria and other mosquito borne disease control’ with an outstanding list of speakers to support the symposium.
The symposium delivered the latest research on an ever-expanding toolbox of vector control tools and approaches and disseminated important findings to the PAMCA membership and wider malaria community to inform future research and implementation of vector control across the African continent. It also made visible to national malaria programmes the diverse and high impact tools that can be integrated into countries’ vector control response now or in the future. Topics covered in this symposium were of significant importance to malaria burden reduction and elimination efforts and the control of other mosquito-borne diseases.
IVCC was a sponsor of PAMCAs 6th annual conference and exhibition
The session was co-chaired by Allison Tatarsky and Mercy Opiyo, Manica Health Research Centre, Mozambique, and ISGlobal, University of Barcelona.
Speakers at the symposium were:
Derric Nimmo, IVCC – Overview of the vector control pipeline and rational for an integrated vector management (IVM) response.
Ingrid Etoke, IVCC – The New New Nets project – project scale up and progress to date
Andrew Saibu, IVCC NgenIRS programme, and Richard Oxborough, Abt Associates– early results from PMI VectorLink rollout of 3rd generation IRS insecticides, Fludora Fusion and SumiShield.
Silas Majambere, Mosquito Consulting – Precision larviciding with drone technology and new longer lasting larvicides for Aedes and Anopheles control
Eric Ochomo, KEMRI/CDC – Ivermectin: results from IVERMAL in Kenya
Lina Finda, IHI – Spatial repellents: community-wide effect of transfluthrin-treated eave ribbonsMajor grant awarded to IVCC 14th June 2016
IVCC is pleased to announce that it has received its third and largest grant from the Bill & Melinda Gates Foundation, with an additional $75million over the next five years. The grant will continue to support IVCC’s work in vector control, especially preserving and expanding gains against malaria by developing innovative vector control products that prevent transmission of malaria from mosquitos to vulnerable populations. In particular, the grant will contribute to development costs of three new insecticides currently in pre-development and other related tools and solutions, the total costs shared with industry and other funders.
Sir Mark Moody Stuart, Chairman of the IVCC Board of Trustees, said, ‘This is a remarkable time for IVCC in its 10th year of discovering and developing new vector control tools. This substantial grant is evidence of the successful journey so far travelled, and we are grateful for the continued support from the Bill & Melinda Gates Foundation and all our partners. Vector control has been shown to have played a major role in the rolling back of malaria over the past 15 years and this grant will help to maintain that momentum through the new public health insecticides that are about to go into full development.’
Dr Nick Hamon, IVCC’s CEO said, ‘We are very pleased to have received this award from the Bill & Melinda Gates Foundation, coming as it does at a crucial point in IVCC’s strategy to provide malaria control programmes with the vector control tools they need to continue the battle to eradicate malaria. We have a full pipeline of novel vector control products, and next year several innovative compounds will go into final development. We are also working with new partners, and new funders to ensure these insecticide resistance-breaking products are delivered cost effectively and speedily to the market.’
IVCC is also supported by funding from UKAID, USAID, the Swiss Agency for Development and Cooperation, and UNITAID.World Mosquito Day announcement from Sumitomo & IVCC 20th August 2015
Sumitomo Chemical and IVCC have been working for the past 5 years to develop a new active ingredient with a novel mode of action for use in the fight against the mosquitoes that transmit malaria and other debilitating and often fatal diseases.
Extensive laboratory based studies demonstrating the safety and efficacy of this chemistry against insecticide resistant mosquitoes have now been completed. On World Mosquito Day, that commemorates the 1897 discovery by Sir Ronald Ross that female mosquitoes transmit malaria, we are delighted to announce these studies have moved to the next phase. This includes evaluating the performance of a range of prototype products in both laboratory and semi-field based settings.
Read the full press release in the attached file.$65 million boost for new insecticide use in Africa 1st February 2016
A new $65 million initiative to boost malaria control was announced today in Geneva. IVCC signed a partnership agreement with Unitaid in a project that will combat resistance to insecticides by improving access to new, low-cost anti-mosquito sprays across Africa.
The Next Generation Indoor Residual Spray project, known as NgenIRS, will support countries in obtaining new and effective insecticides at lower prices to spray walls in homes and fight growing insecticide resistance. Over four years, the project aims to protect as many as 50 million people from malaria in 16 African countries. Despite its effectiveness in combating malaria, indoor spraying of walls has fallen by 40 per cent in the past four years. The drop is due to increased resistance of mosquitoes to older products and higher cost of new alternatives.
IVCC will team up with the US President’s Malaria Initiative, Abt Associates, PATH and the Global Fund to work with industry and country malaria-control programmes to make alternative insecticides with high efficacy more readily available in countries with a high burden of malaria. The initiative will use a co-payment from Unitaid to bring down the price of these new and more effective products in the short term.
A further aim is to reduce the cost of procuring products in the long term through improved forecasting and increased competition among manufacturers.
Welcoming the project, Dr Nick Hamon, IVCC CEO said, “recent evidence has shown that insecticides are the first line of defence against malaria, responsible for nearly 80 per cent of malaria cases averted since 2000. We are working with our industry partners to bring to market as soon as possible novel insecticides that are in the pipeline.’
Lelio Marmora, Executive Director of Unitaid said that the initiative would bolster the central role of insecticides in controlling malaria. “If the insecticide resistance continues to spread unabated, there could be 120,000 more deaths from malaria a year”, he said. “Unless newer insecticides are used, we run the risk of considerable reversals in the fight against malaria. This is the first of many other initiatives by Unitaid to control the spread of malaria-transmitting mosquitoes.”
Speaking at the launch of the project, Dr Pedro Alonso, Director of the WHO Global Malaria Programme, said that it would help maintain the effectiveness of vector control in the short term and encourage competition as prices decrease and demand grows. “Effective vector control is a cornerstone of our global strategy for malaria,’ he said. “It is responsible for many of the gains seen over the last decade in malaria control and elimination. We welcome this joint initiative to accelerate the development and deployment of new insecticides and vector control tools.”
Find out more at www.ivcc.com/market-access/ngenirs/